Retrospective observational study of role of platelet rich plasma in osteoarthrosis of knee joint among Indian population
DOI:
https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20254086Keywords:
Knee, Knee joint osteoarthrosis, Platelet-rich plasma, OsteoarthrosisAbstract
Background: Direct release of platelet-derived factors at the site of cartilage disease, especially knee osteoarthrosis (OA), may promote tissue repair by further mediating the anti-inflammatory response and stimulating the natural regeneration signalling cascade. The study's objective was to assess how well platelet rich plasma (PRP) injections worked to improve joint function and lessen pain in Indian patients with osteoarthrosis of the knee.
Methods: The study was a retrospective, observational. It was a multi-centric study. The retrieved study data covered one year. Data of 150 participants were retrieved for the study. The study comprised patients between the ages of 40 and 75 who had knee osteoarthrosis (Kellgren–Lawrence grade I–III) that was confirmed by radiography and clinical examination. Only individuals who had received intra-articular PRP injections with at least six months of follow-up data, experienced chronic knee pain that lasted longer than three months, and were not responding to conservative treatment were eligible.
Results: The mean WOMAC score for patients with grade I–II OA (n=93) increased by 49.3%, from 66.1±7.3 at baseline to 33.5±5.4 after six months. On the other hand, the WOMAC score increased by 31.8% in grade III OA patients (n=57), from 72.1±6.8 to 49.1±5.7. In terms of pain and function, 65 patients (43.3%) reported good improvement and 58 patients (38.7%) reported outstanding improvement.
Conclusion: In patients with knee osteoarthrosis, especially in the early and intermediate phases of the condition, PRP therapy greatly reduced discomfort and improved functional outcomes.
Metrics
References
Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I. Caspian J Internal Med. 2011;2(2):205.
Hayami TA. Osteoarthritis of the knee joint as a cause of musculoskeletal ambulation disability symptom complex (MADS). Clin Calcium. 2008;18(11):1574-80.
Raeissadat SA, Rayegani SM, Hassanabadi H, Fathi M, Ghorbani E, Babaee M, et al. Knee Osteoarthritis Injection Choices: Platelet- Rich Plasma (PRP) Versus Hyaluronic Acid (A one-year randomized clinical trial). Clin Med Insights Arthritis Musculoskelet Disord. 2015;8:1-8. DOI: https://doi.org/10.4137/CMAMD.S17894
Idzko M, Pitchford S, Page C. Role of platelets in allergic airway inflammation. J Allergy Clin Immunol. 2015;135(6):1416-23. DOI: https://doi.org/10.1016/j.jaci.2015.04.028
Gato-Calvo L, Magalhaes J, Ruiz-Romero C, Blanco FJ, Burguera EF. Platelet-rich plasma in osteoarthritis treatment: review of current evidence. Thera Adv Chronic Dis. 2019;10:2040622319825567. DOI: https://doi.org/10.1177/2040622319825567
Drengk A, Zapf A, Stürmer EK, Stürmer KM, Frosch KH. Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs. 2009;189(5):317-26. DOI: https://doi.org/10.1159/000151290
Mascarenhas R, Saltzman BM, Fortier LA, Cole BJ. Role of platelet-rich plasma in articular cartilage injury and disease. J Knee Surg. 2015;28(01):003-10. DOI: https://doi.org/10.1055/s-0034-1384672
Lana JF, Weglein A, Sampson SE, Vicente EF, Huber SC, Souza CV, et al. Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee. J Stem Cells Regenr Med. 2016;12(2):69. DOI: https://doi.org/10.46582/jsrm.1202011
Spaková T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Physical Med Rehab. 2012;91(5):411-7. DOI: https://doi.org/10.1097/PHM.0b013e3182aab72
Raeissadat SA, Rayegani SM, Ahangar AG, Abadi PH, Mojgani P, Ahangar OG. Efficacy of intra-articular injection of a newly developed plasma rich in growth factor (PRGF) versus hyaluronic acid on pain and function of patients with knee osteoarthritis: a single-blinded randomized clinical trial. Clin Med Insights Arthritis Musculoskelet Dis. 2017;10:1179544117733452. DOI: https://doi.org/10.1177/1179544117733452
Filardo G, Di Matteo B, Di Martino A, Merli ML, Cenacchi A, Fornasari P, et al. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial. Am J Sports Med. 2015;43(7):1575-82. DOI: https://doi.org/10.1177/0363546515582027
Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Physical Med Rehab. 2010;89(12):961-9. DOI: https://doi.org/10.1097/PHM.0b013e3181fc7edf
Anitua E, Sánchez M, Orive G. Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev. 2010;62(7-8):741-52. DOI: https://doi.org/10.1016/j.addr.2010.01.001
Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):472-9. DOI: https://doi.org/10.1007/s00167-009-0940-8
Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013;41(2):356-64. DOI: https://doi.org/10.1177/0363546512471299
Downloads
Published
How to Cite
Issue
Section
